Automated ESR Analyzer Market Forecasts to 2030 – Global Analysis By Type (Semi-Automated ESR Analyzer and Fully Automated ESR Analyzer), Analysis Time (Less Than 15 Min, 15-30 Min and More Than 30 Min), Modality, Application, End User and By Geography

Automated ESR Analyzer Market Forecasts to 2030 – Global Analysis By Type (Semi-Automated ESR Analyzer and Fully Automated ESR Analyzer), Analysis Time (Less Than 15 Min, 15-30 Min and More Than 30 Min), Modality, Application, End User and By Geography

According to Stratistics MRC, the Global Automated ESR Analyzer Market is accounted for $375.72 million in 2023 and is expected to reach $595.47 million by 2030 growing at a CAGR of 6.8% during the forecast period. The automated erythrocyte sedimentation rate (ESR) analyzer calculates the rate in mm per hour at which red blood cells from whole blood fall into a standard tube. Automated ESR analyzers deliver prompt and precise findings while cutting down on the labor-intensive manual work and potential mistakes that come with conventional manual methods of ESR measurement. In practical practice, it aids in preventing the rejection of several samples. Rapid and accurate ESR readings are produced using an automated technique, which also exhibits excellent agreement with the conventional Westergreen reference method. Modern ESR methods do not require further dilution, which enhances operator security, optimizes logistical laboratory process, and reduces waste.

According to the World Health Organization, by worldwide ESR reports in 2018, healthcare associated infection was about 10% and surgical site infections were 50%.

Market Dynamics

Driver

Growing government investments

Governments all across the world are spending additional funds on cutting-edge medical testing technology. Infection rates are high in several countries, including Japan, China, and India. Governments are making large expenditures to provide greater health and well-being for more people. To lessen the burden of providing healthcare, several regulatory bodies and governments, particularly in developed economies, are putting in place a variety of cost-cutting measures. All of these factors boost the market demand.

Restraint

Risk of infections

Medical personnel who handle blood samples run a very real risk of contracting a blood-borne illness. The most prevalent causes of a highly increased ESR (>100 mm/hr) include infection, significant blood loss, malignancy, or temporal arthritis. They may result in renal or cancer disorders. Therefore, in order to prevent such issues, local testing centers and unskilled operators should not be encouraged. Therefore, the threat of infections is impeding market expansion even more.

Opportunity

Technological advancements

In order to offer a quick detection rate, manufacturers are creating cutting-edge equipment like automated ESR analyzers. The newest developments in analyzers give ESR findings straight from EDTA tubes without using the patient sample. These analyzers have cutting-edge programming, upgraded measuring algorithms, and increased data-handling capabilities. The development of automated ESR analyzers beyond manual ESR analyzers is currently possible because to technological advancements, which are influencing the worldwide market.

Threat

Lack of adequate professionals

ESR analyzers are intricate devices that need for qualified personnel to do blood tests and provide correct findings. Unskilled technicians may make mistakes in order input, patient and specimen identification, sample collection, and incorrect test requests. Patients still run a considerable risk of developing problems. Low-income nations may experience difficulties meeting market demand due to a lack of qualified personnel.

Covid-19 Impact

The covid pandemic has the positive impact on the market. As the virus spread rapidly, it became necessary for all the people around the world to have blood tests. Blood test analysis is used as an alternative for identifying COVID-19-positive patients. The patient's complete blood count (CBC), plasma levels of C-reactive protein (CRP), and erythrocyte sedimentation rate were all examined using ESR analyzers. The laboratories received accurate outcomes in a shorter amount of time because of the automated ESR analyzers. Every day, thousands of blood tests were carried out. The epidemic profited the market hugely.

The fully automated ESR analyzer segment is expected to be the largest during the forecast period

The fully automated ESR analyzer segment is estimated to have a lucrative growth. Fully automated analyzers enhance productivity, turnaround time, and lab security. From the moment the sample tube is inserted, it allows walk-away operation. This makes it more practical than ESR analyzers that are semi-automated. The analysis of paediatric patients is made simpler when cutting-edge, completely automated analyser models are employed. The segment's growth is being fuelled by these factors.

The portable segment is expected to have the highest CAGR during the forecast period

The portable segment is anticipated to witness the fastest CAGR growth during the forecast period. Portable ESR analyzers are portable devices that employ the Westergren analysis technique and the infrared sensor measuring idea. They have an hourly processing rate of up to 80 samples and a measurement range of 1 to 140 mm/h. The majority of devices have two measurement times of 30 or 60 minutes each and a maximum simultaneous sample loading capacity of 40. The segment's demand is being fueled by its benefits for user-friendly and simple patient identification.

Region with largest share

Europe is projected to hold the largest market share during the forecast period owing to the rising prevalence of disorders such infection, inflammation, heart disease, blood disease, diabetes, and collagen vascular diseases. Europe is a key area of attention for getting accurate and current global cancer statistics due to its large contribution to the global cancer burden. It is very likely that demand for automated ESR analyzers will stay high in Germany as cancer prevalence grows since ESR analyzers are linked to the symptoms of present malignancies.

Region with highest CAGR

Asia Pacific is projected to have the highest CAGR over the forecast period, owing to raising blood borne infections. Inadequate sanitation conditions in this region are the main criteria for growing infections among population. With the introduction of fully automated laboratory systems in the Asia Pacific area, Japan now enjoys a greater market share globally. This is attributed to the large geriatric population bringing in a heavy disease burden associated with age-related disorders. Additionally, the region's industry is growing as a result of the government's focus on enhancing the healthcare infrastructure and offering the populace improved healthcare facilities.

Key players in the market

Some of the key players profiled in the Automated ESR Analyzer Market include ALCOR Scientific Inc, RR Mechatronics, Beijing Succeeder Technology Inc, Streck Inc, ELITechGroup, Greiner Bio One International GmbH, SFRI Medical Diagnostics, Alifax Holding S.p.A., Thermo Fisher Scientific Inc, Diesse Diagnostica Senese SPA, Hospitex Diagnostics, Caretium Medical Instruments Co, Streck Laboratories, Beckman Coulter Inc and Perlong Medical Equipment Co Ltd.

Key Developments

In May 2023, Beckman Coulter, a clinical diagnostics leader, unveiled the DxI 9000 Access Immunoassay Analyzer, the most productive immunoassay analyzer per footprint. The DxI 9000 Analyzer can run up to 215 tests per hour per square meter (tests/hr/m2). The DxI 9000 Analyzer innovations address speed, reliability, reproducibility, quality, and menu expansion demands.

In March 2022, Thermo Fisher Scientific introduced its latest generation of SeqStudio Flex Series Genetic Analyzer to enable customers' cutting-edge research in areas such as gene editing and infectious disease. The SeqStudio Flex Genetic Analyzer delivers the gold-standard quality of CE technology with accurate data and reliable performance.

Types Covered
• Semi-Automated ESR Analyzer
• Fully Automated ESR Analyzer

Analysis Time Covered
• Less Than 15 Min
• 15-30 Min
• More Than 30 Min

Modalities Covered
• Portable
• Bench Top
• Compact
• Other Modalities

Applications Covered
• Scientific Research
• Medical Application
• Clinical Laboratories
• Pharmaceutical Industry
• Research Methodology
• Other Applications

End Users Covered
• Hospitals
• Diagnostic Centers
• Contract Research Organizations
• Academic & Research Institutes
• Ambulatory Surgical Centers
• Emergency Medical Services
• Blood Banks
• Academic Institutions
• Other End Users

Regions Covered
• North America
US
Canada
Mexico
• Europe
Germany
UK
Italy
France
Spain
Rest of Europe
• Asia Pacific
Japan
China
India
Australia
New Zealand
South Korea
Rest of Asia Pacific
• South America
Argentina
Brazil
Chile
Rest of South America
• Middle East & Africa
Saudi Arabia
UAE
Qatar
South Africa
Rest of Middle East & Africa

What our report offers
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements Show more